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Abstract - In this paper, we study the relationship between 
diagnosis and therapeutic decision on the one hand and the 
observations of the presence of ABCD features and some 
additional dermoscopic features of pigmented skin tumors 
on the other hand. The image database was composed of 
227 images of pigmented skin lesions. Five senior 
dermatologists were asked for their expertise about these 
images. They gave their opinion about the presence of 
ABCD and dermoscopic features, their diagnosis and their 
therapeutic decision. The performances of dermatologists 
were evaluated in terms of their ability to diagnose 
melanoma by building statistical decision models from their 
observations of predictive features. Models allowed 
observing to what extent dermatologists ground their 
diagnosis on the malignancy features they detected. It 
appeared that a high variability of behavior among 
dermatologists is observed, concerning both the detection of 
features and the role of features for the elaboration of 
diagnosis.  
Keywords: ABCD features, melanoma diagnosis, decision 
model, Roc curve, Medicine Data Mining. 
 
1 Introduction 
As the survival rate of malignant melanoma depends on its 
thickness, diagnosis of malignant melanoma at an early stage 
could reduce the risk of mortality and increase the chance of 
prognosis considerably. The accuracy of the clinical 
diagnosis of melanoma with the unaided eye is only about 
60%. Dermoscopy is a non-invasive in vivo technique for 
the microscopic examination of pigmented skin lesions, has 
the potential to improve the diagnostic accuracy [1]. 
Advances in objective dermatology diagnosis were obtained 
in 1994 with the introduction of the ABCD rule [2-3]. The 
ABCD rule specifies a list of visual features associated to 
malignant lesions (Asymmetry, Border irregularity, Color 
irregularity and Differential structure, i.e. size and number of 
structural features), from which a score is computed [4]. 
This methodology provided clinicians with a useful 
quantitative criterion, but it did not prove efficient enough 
for clinically doubtful lesions (CDL) essentially because 
ABCD features are difficult to characterize in those 
situations [5]. 
According to dermatologists’ ‘rules of good clinical 
practice’, the diagnosis and associated therapeutic decision 
for black skin tumors is a multi-step procedure. The first step 
consists in detecting malignancy features (ABCD rule, 7-
points checklist [6], etc.). In the second step, dermatologists 
combine these features according to their capacity in 
predicting malignancy. Stolz et al. has formulated a 
mathematical implementation of the ABCD rule [4]. Given 
that feature A may get a score varying from 0 to 2, feature B 
a score varying from 0 to 8, feature C a score varying from 1 
to 6 and feature D a score varying from 1 to 5, a decision 
score (TDS) may be obtained by a linear combination of the 
features. 
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Tumors being given a TDS higher than 5.45 are 
considered highly suggestive of melanoma, an excision is 
recommended for tumors with a TDS higher than 4.8. 
In order to build dermatologists’ models of 
diagnosis/therapeutic decision, five senior dermatologists 
were asked to give their diagnosis and therapeutic decision 
for 227 images of tumors, together with their opinion about 
the existence of malignancy features (presence/absence). 
‘Models’ of dermatologists were subsequently built by 
connecting predicted features to the so-called “gold 
standard” diagnostic (see below). 
2 Materials and methods 
The initial dataset used in this study was collected at the 
dermatology departments of the British Hertfort Hospital 
and the Louis Mourier Hospital in ‘Ile de France’ (France). 
A total of 900 images of pigmented skin lesions were 
  
acquired in ‘uncontrolled’ conditions (see [7]). As a 
consequence of the inclusion protocol, many tumors were 
quite similar, and melanomas were largely in a minority. The 
current working database that initially included all identified 
melanoma lesions has been completed to 227 with randomly 
selected tumors. On doing so, it appeared that 77 lesions 
were classified as benign lesions. In order not to cause any 
needless distress to the patient, the majority of benign 
lesions were not surgically excised. Dysplastic lesions (i.e. 
atypical lesions, for which malignity may be suspected) were 
118 in the database. Thirty-two pigmented lesions were 
categorized as malignant melanomas. The malignant 
melanomas and the dysplastic lesions were all surgically 
excised and histopathologically analyzed. 
 
Fig. 1. Four nevi that fulfill ABCD rule (+) and four others that do not (-). 
 
For this study, two classes were finally considered: 
histologically confirmed melanomas on the one hand and the 
remaining lesions on the other. For simplicity, this 
classification is referred to as the ‘gold standard’ diagnosis 
in this study. 
Five senior dermatologists were asked for their expertise 
about the 227 selected images. They were presented each 
tumor both as macroscopic image and dermoscopic image. 
They subsequently gave their opinion about the presence of 
ABCD and dermoscopic features (dichotomic answers), their 
diagnosis (melanoma, dysplastic or benign lesion) and their 
therapeutic decision (dichotomic answer, excision/non-
excision). Mimicking the Stolz’s linear decision model, a 
logistic regression classifier [8] was built for each 
dermatologist using the features they reported as input and 
the ‘gold standard’ diagnosis as output, while a leave-one-
out cross-validation was employed. The classifiers provide a 
probability to be a melanoma for each tested lesion in the 
selected database. ROC curves were built from these 
probabilities. They allows further analyzing the whole set of 
sensitivity/specificity couples of parameters. The area under 
the ROC curves (AUC) is a measure of the quality of 
prediction. 
3 Results 
As far as the diagnosis is concerned, one may observe a 
high variability of sensitivity among dermatologists whereas 
specificity remains similar, with the exception of the one 
obtained by dermatologist 3 (Table I).  
 
TABLE I 
Dermatologists’ performances 
Diagnosis and 
therapeutic 
decision 
Diagnosis 
Sensitivity/Specificity 
Therapeutic decision 
Sensitivity/Specificity 
Dermatologist 1 0.62 / 0.90  0.84 / 0.63 
Dermatologist 2 0.78 / 0.85 0.93 / 0.63 
Dermatologist 3 0.59 / 0.71 0.84 / 0.39 
Dermatologist 4 0.81 / 0.90 0.84 / 0.55 
Dermatologist 5 0.71 / 0.80 0.87 / 0.63 
Sensitivity and specificity are calculated with respect to the ‘gold standard’ 
diagnosis of melanoma. 
Asymmetry Border Irregularity Color Differential Structural 
+ 
- 
  
In fact, the analysis of dermatologists’ performances 
requires considering several factors. Sensitivity and 
specificity express the efficiency of the clinicians, but also 
the trade-off they believe to be acceptable with respect to the 
risk for a false diagnosis (Table I). 
Depending on their level of confidence, they may 
privilege sensitivity over specificity. The opposite may also 
be true since it is a “risk-free” trial. The prior frequency of 
melanoma they meet usually in their daily practice may also 
play a role. 
All these factors also take part in the therapeutic decision, 
although a much smaller one. In fact, we can expect (and 
observe) the therapeutic decision to have a higher sensitivity 
(as far as the prediction of melanoma is concerned), together 
with a lower specificity, since the CDL worthy of an 
excision encompasses melanoma. At the therapeutic decision 
level, sensitivities are more comparable, most melanomas 
are detected, but the cost (specificity) highly varies from one 
dermatologist to another. 
 
Fig. 2. Roc Curves for melanoma diagnosis result from logistic regression based on the features detected by each dermatologist. Mi and Ei show the accuracy 
of dermatologist i' diagnosis and therapeutic decision (Panels 1 to 5). 
The last panel (bottom right) shows the Roc Curve of the logistic regression based on the consensual detected features (dotted line), together with the 
diagnosis and the therapeutic decision of each dermatologist. The 5-point solid line results from the voting schema about diagnosis so that the lower point 
corresponds to the tumors reported as melanoma by each of the 5 dermatologists, the next point corresponds to the tumors reported as melanoma by 4 out of 
the 5 dermatologists and so on. 
Dermatologist’ performances are shown, one at a time, in 
the subplots of Fig. 2. Sensitivity and specificity are 
displayed together with a ROC curve obtained with the 
mentioned linear classifier. It can be seen that dermatologist 
1 grounds its diagnosis on the mere basis of the features he 
detected. Dermatologists 2, 4 and 5 probably use of 
additional visual features not available to the classifier, 
which makes their diagnosis and therapeutic decisions better 
than the results obtained by the classifier. Finally, 
dermatologist 3 seems poorly combining the features he has 
however efficiently detected. The best classifier performance 
is obtained from the set of features detected by the 
dermatologist 3, as shown by the AUC, which is the highest 
in this study.  
Combining dermatologists’ diagnoses and features 
characterization allows evaluation of the efficiency of the 
group of experts together. As dermatologists do not 
necessarily agree about the presence of features, diagnosis 
and therapeutic decision, a voting schema has been 
implemented (see reference [7] for details). It showed that 
full agreement between dermatologists is high (60%) as far 
as diagnosis is concerned, whereas therapeutic decision is 
more disputed (36%) (Table II). The picture is contrasted for 
the features: The agreement is high for asymmetry and 
relatively poor for color irregularity (Table II). 
 
 
  
TABLE II 
Distribution of the 227 images for ABCD features as a function of the 
dermatologists’ vote 
Feature 0-5 1-4 2-3 
Asymmetry 54% 26% 20% 
Border 36% 38% 26% 
Color 34% 38% 28% 
Differential structure 46% 30% 24% 
Diagnosis 60% 23% 17% 
Excision 36% 36% 28% 
0-5 indicates that the 5 dermatologists are in full agreement, 1-4 indicates 
that 1 out of the 5 dermatologists disagrees and so on. 
 
Combining diagnosis provides a remarkable result (Fig. 2, 
last panel, highest point of the 5-point solid line): 31 out of 
32 melanomas are detected (sensitivity = 0.97) while cost 
remains low (specificity = 0.60). In contrast, the 
“consensual” ROC curve (AUC = 0.83) provided by the 
logistic model based on the consensual detected features 
does not reach the best available performance (0.87, Fig 2).  
Finally, the Stotz’s formula, lightly adapted to fit our 
protocol, get an AUC of 0.79, which is quite good in this 
context. 
4 Conclusion 
In this study, five senior dermatologists were asked for 
their expertise about the 227 selected images. Models of 
diagnosis and therapeutic decision based on the observations 
of the presence of ABCD and dermoscopic features have 
been presented and evaluated. The results obtained show that 
the variability of performance of dermatologists is high, 
dermatologists with a melanoma-specific hospital activity 
showing the best performance, both for the diagnosis and the 
therapeutic decision.  
The sensitivity and the specificity for diagnosis as well as 
therapeutic decision are higher if clinicians’ advices are 
pooled. Such a result was not always assured, given the false 
positives to be cumulated. 
Models also allow observing to what extent dermatologists 
ground their diagnosis on the malignancy features they 
detected. We believe that the clinical experience (based on 
the learning by sample paradigm) they gain during their 
daily practice is the key to their success. 
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